Who makes Ferricarboxymaltose?

Ferricarboxymaltose is developed by Amsterdam UMC, location VUmc.

What development phase is Ferricarboxymaltose in?

Ferricarboxymaltose is FDA-approved (marketed).

Last reviewed 2026-04-20 · How we verify

Ferricarboxymaltose

Amsterdam UMC, location VUmc · FDA-approved active Small molecule Quality 1/100

At a glance

Generic name	Ferricarboxymaltose
Also known as	Ferinject
Sponsor	Amsterdam UMC, location VUmc
Modality	Small molecule
Therapeutic area	Other
Phase	FDA-approved

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Key clinical trials

Iron Substitution After Upper Gastro-Intestinal Bleeding (PHASE4)
Iron Deficiency In Pulmonary Hypertension (PHASE4)

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

Source	Used for
ClinicalTrials.gov	Trial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

Ferricarboxymaltose CI brief — competitive landscape report
Ferricarboxymaltose updates RSS · CI watch RSS
Amsterdam UMC, location VUmc portfolio CI